Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Clinical and virologic outcomes in patients with oseltamivir-resistant seasonal influenza A (H1N1) infections: results from a clinical trial.

Dharan NJ, Fry AM, Kieke BA, Coleman L, Meece J, Vandermause M, Gubareva LV, Klimov AI, Belongia EA.

Influenza Other Respir Viruses. 2012 May;6(3):153-8. doi: 10.1111/j.1750-2659.2011.00312.x.

2.

Emerging oseltamivir resistance in seasonal and pandemic influenza A/H1N1.

Renaud C, Kuypers J, Englund JA.

J Clin Virol. 2011 Oct;52(2):70-8. doi: 10.1016/j.jcv.2011.05.019. Review.

PMID:
21684202
3.

Emergence of oseltamivir resistance: control and management of influenza before, during and after the pandemic.

Dixit R, Khandaker G, Ilgoutz S, Rashid H, Booy R.

Infect Disord Drug Targets. 2013 Feb;13(1):34-45. Review.

PMID:
23675925
4.

Oseltamivir-resistant pandemic H1N1 influenza.

Webster D, Li Y, Bastien N, Garceau R, Hatchette TF.

CMAJ. 2011 Apr 19;183(7):E420-2. doi: 10.1503/cmaj.100313. Review. No abstract available.

5.

Influenza viruses resistant to neuraminidase inhibitors.

Nitsch-Osuch A, Brydak LB.

Acta Biochim Pol. 2014;61(3):505-8. Review.

6.

Preventing and treating secondary bacterial infections with antiviral agents.

McCullers JA.

Antivir Ther. 2011;16(2):123-35. doi: 10.3851/IMP1730. Review.

Supplemental Content

Support Center